Celgene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Celgene and buy or sell other stocks, ETFs, and their options commission-free!About CELG
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza.
CEOMark J. Alles
CEOMark J. Alles
Employees—
Employees—
HeadquartersSummit, New Jersey
HeadquartersSummit, New Jersey
Founded1986
Founded1986
Employees—
Employees—
CELG Key Statistics
Market cap77.04B
Market cap77.04B
Price-Earnings ratio13.32
Price-Earnings ratio13.32
Dividend yield—
Dividend yield—
Average volume27.24M
Average volume27.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$110.70
52 Week high$110.70
52 Week low$58.59
52 Week low$58.59